Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY (Details Narrative)

v3.23.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 18, 2023
May 24, 2023
Aug. 31, 2022
Feb. 01, 2022
May 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Jun. 14, 2023
Dec. 31, 2022
Aug. 24, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, shares authorized           250,000,000   250,000,000     100,000,000  
Common stock, par value           $ 0.00001   $ 0.00001     $ 0.00001  
Preferred stock, shares authorized           5,000,000   5,000,000     5,000,000  
Preferred stock, par value           $ 0.00001   $ 0.00001     $ 0.00001  
Proceeds from issuance of common stock $ 571,400       $ 4,000,000              
Exercise price     $ 5.45     $ 14.25   $ 14.25        
Number of shares reserved for future issuance           21,623,189   21,623,189        
Number of warrants issued     3,411,596                  
Warrants expire date     Aug. 24, 2027                  
Other expense               $ 2,223,356 $ 2,642,139      
Note Warrants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price                       $ 14.25
Warrants issued shares                       1,811,595
Note Warrants [Member] | Placement Agent [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price                       $ 17.8125
Warrants issued shares                       120,773
Warrants and Rights Outstanding, Maturity Date                       Feb. 24, 2028
Common Stock Warrants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price           $ 3.61   $ 3.61     $ 11.67  
Exchange of warrants exercised               307,001        
Warrants exercise price               $ 1.75        
Other expense           $ 0 $ 0 $ 0 $ 7,302      
Reload Warrants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price           $ 2.50   $ 2.50        
Number of warrants issued           307,001   307,001        
Warrants expire date               Aug. 24, 2027        
Reserved For Conversion Of Notes And Exercise Of Warrants [Member] | May 2023 Warrants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares reserved for future issuance           120,773   120,773        
Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, shares authorized                   250,000,000    
Common stock, par value                   $ 0.00001    
Number of shares sold, shares 280,000 1,200,000   1,333,334                
Share price $ 2.50 $ 3.75   $ 15.00                
Proceeds from issuance of common stock $ 571,400 $ 3,998,700   $ 18,089,184                
Commissions and expenses $ 128,600 $ 501,300   $ 1,910,816                
Warrant to purchase 56,000     66,667                
Exercise price $ 3.13     $ 18.75                
Expiration date 5 years 6 months     5 years 6 months                
Preferred Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Preferred stock, shares authorized                   5,000,000    
Preferred stock, par value                   $ 0.00001    
Warrant [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Purchase of warrants         1,811,595              
Exchange warrants purchase         3,411,595              
Exercise price increase         $ 5.45              
Exercise price decrease         $ 3.75              
Warrants issued shares         1,086,957